AT84977T - Gastric back entertainment system for controlled drug donation. - Google Patents

Gastric back entertainment system for controlled drug donation.

Info

Publication number
AT84977T
AT84977T AT89304873T AT89304873T AT84977T AT 84977 T AT84977 T AT 84977T AT 89304873 T AT89304873 T AT 89304873T AT 89304873 T AT89304873 T AT 89304873T AT 84977 T AT84977 T AT 84977T
Authority
AT
Austria
Prior art keywords
donation
gastric
entertainment system
controlled drug
back entertainment
Prior art date
Application number
AT89304873T
Other languages
German (de)
Inventor
William John Curatolo
Jeelin Lo
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US07/200,801 priority Critical patent/US5002772A/en
Application filed by Pfizer filed Critical Pfizer
Publication of AT84977T publication Critical patent/AT84977T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
AT89304873T 1988-05-31 1989-05-15 Gastric back entertainment system for controlled drug donation. AT84977T (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US07/200,801 US5002772A (en) 1988-05-31 1988-05-31 Gastric retention system for controlled drug release

Publications (1)

Publication Number Publication Date
AT84977T true AT84977T (en) 1993-02-15

Family

ID=22743251

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89304873T AT84977T (en) 1988-05-31 1989-05-15 Gastric back entertainment system for controlled drug donation.

Country Status (19)

Country Link
US (2) US5002772A (en)
EP (1) EP0344939B1 (en)
JP (1) JPH0229268A (en)
KR (1) KR910009396B1 (en)
AT (1) AT84977T (en)
AU (1) AU609995B2 (en)
CA (1) CA1335351C (en)
DE (2) DE68904596T2 (en)
DK (1) DK262789A (en)
ES (1) ES2037419T3 (en)
FI (1) FI99081C (en)
GR (1) GR3007271T3 (en)
HU (1) HUT50626A (en)
IE (1) IE62761B1 (en)
IL (1) IL90395A (en)
NO (1) NO178426C (en)
NZ (1) NZ229324A (en)
PT (1) PT90702B (en)
ZA (1) ZA8904053B (en)

Families Citing this family (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002772A (en) * 1988-05-31 1991-03-26 Pfizer Inc. Gastric retention system for controlled drug release
NZ228382A (en) * 1989-03-17 1992-08-26 Carter Holt Harvey Plastic Pro Drug administering coil-like device for insertion in body cavity of animal
JPH03163011A (en) * 1989-08-31 1991-07-15 Yamanouchi Pharmaceut Co Ltd Device stayed in stomach
US5091190A (en) * 1989-09-05 1992-02-25 Alza Corporation Delivery system for administration blood-glucose lowering drug
USRE44459E1 (en) * 1989-09-05 2013-08-27 Alza Corporation Method for lowering blood glucose
US5591454A (en) * 1989-09-05 1997-01-07 Alza Corporation Method for lowering blood glucose
US5024843A (en) * 1989-09-05 1991-06-18 Alza Corporation Oral hypoglycemic glipizide granulation
US5922342A (en) * 1990-10-01 1999-07-13 Pharmacia & Upjohn Company Lateral edge coated controlled release pharmaceutical compositions
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
EP0820258B1 (en) * 1995-03-23 2002-10-09 Advanced Animal Technology Limited Substance delivery device
US5683718A (en) * 1995-04-04 1997-11-04 Time-Cap Labs, Inc. Enteric coated tablet with raised identification character and method of manufacture
WO1999007342A1 (en) * 1997-08-11 1999-02-18 Alza Corporation Prolonged release active agent dosage form adapted for gastric retention
IN186245B (en) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd Process for the preparation of a pharmaceutical composition in the form of oral controlled release tablets or capsules
US6635281B2 (en) 1998-12-23 2003-10-21 Alza Corporation Gastric retaining oral liquid dosage form
US6797283B1 (en) 1998-12-23 2004-09-28 Alza Corporation Gastric retention dosage form having multiple layers
US7708712B2 (en) * 2001-09-04 2010-05-04 Broncus Technologies, Inc. Methods and devices for maintaining patency of surgically created channels in a body organ
US20050060041A1 (en) * 2001-09-04 2005-03-17 Broncus Technologies, Inc. Methods and devices for maintaining surgically created channels in a body organ
US7815590B2 (en) 1999-08-05 2010-10-19 Broncus Technologies, Inc. Devices for maintaining patency of surgically created channels in tissue
US8002740B2 (en) 2003-07-18 2011-08-23 Broncus Technologies, Inc. Devices for maintaining patency of surgically created channels in tissue
IL133196D0 (en) 1999-11-29 2001-03-19 Yissum Res Dev Co Gastroretentive controlled release pharmaceutical dosage forms
DE10014588A1 (en) 2000-03-27 2001-10-04 Basf Ag Sustained-release oral dosage form that floats in gastric fluid includes a blend of polyvinyl acetate and polyvinylpyrrolidone
US7674480B2 (en) * 2000-06-23 2010-03-09 Teva Pharmaceutical Industries Ltd. Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
EP1245227A1 (en) * 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
US8409167B2 (en) 2004-07-19 2013-04-02 Broncus Medical Inc Devices for delivering substances through an extra-anatomic opening created in an airway
US20030050648A1 (en) 2001-09-11 2003-03-13 Spiration, Inc. Removable lung reduction devices, systems, and methods
NZ514279A (en) * 2001-09-20 2004-02-27 Ashmont Holdings Ltd Intraruminal device for dispensing medication where device has arms that open to keep the device in the animal's rumen after a constraint device dissolves
TWI312285B (en) 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
US20030091630A1 (en) * 2001-10-25 2003-05-15 Jenny Louie-Helm Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
US20030104052A1 (en) * 2001-10-25 2003-06-05 Bret Berner Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US6592594B2 (en) * 2001-10-25 2003-07-15 Spiration, Inc. Bronchial obstruction device deployment system and method
US20060159743A1 (en) * 2001-10-25 2006-07-20 Depomed, Inc. Methods of treating non-nociceptive pain states with gastric retentive gabapentin
CA2409552A1 (en) 2001-10-25 2003-04-25 Depomed, Inc. Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US7612112B2 (en) 2001-10-25 2009-11-03 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
US6929637B2 (en) * 2002-02-21 2005-08-16 Spiration, Inc. Device and method for intra-bronchial provision of a therapeutic agent
US20030181922A1 (en) 2002-03-20 2003-09-25 Spiration, Inc. Removable anchored lung volume reduction devices and methods
US20030216769A1 (en) 2002-05-17 2003-11-20 Dillard David H. Removable anchored lung volume reduction devices and methods
KR20050083750A (en) * 2002-10-11 2005-08-26 디포메드 디벨롭먼트 리미티드 Gastr0-retentive levodopa delivery form
US7485322B2 (en) * 2002-12-24 2009-02-03 Lek Pharmaceuticals D.D. Modified release pharmaceutical composition
US7100616B2 (en) 2003-04-08 2006-09-05 Spiration, Inc. Bronchoscopic lung volume reduction method
US7554452B2 (en) * 2003-07-18 2009-06-30 Cary Cole Ingestible tracking and locating device
US8308682B2 (en) 2003-07-18 2012-11-13 Broncus Medical Inc. Devices for maintaining patency of surgically created channels in tissue
US7533671B2 (en) 2003-08-08 2009-05-19 Spiration, Inc. Bronchoscopic repair of air leaks in a lung
DE102004031014A1 (en) * 2004-06-26 2006-01-12 Raumedic Ag A device for targeted Freistzung of substances in a cavity
IL166183D0 (en) * 2005-01-06 2006-01-15 Yissum Res Dev Co Novel diagnostic and imaging techniques of the gi tract
JP2008526461A (en) * 2005-01-19 2008-07-24 センティネル・グループ・エルエルシーSentinel Group, LLC Drug delivery systems and methods
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
US8730031B2 (en) 2005-04-28 2014-05-20 Proteus Digital Health, Inc. Communication system using an implantable device
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
PT1889198E (en) 2005-04-28 2015-03-06 Proteus Digital Health Inc Pharma-informatics system
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
US8216266B2 (en) * 2005-06-16 2012-07-10 Hively Robert L Gastric bariatric apparatus with selective inflation and safety features
EP1906830B1 (en) * 2005-07-26 2013-09-04 Ram Weiss Extending intrabody capsule
US8021384B2 (en) * 2005-07-26 2011-09-20 Ram Weiss Extending intrabody capsule
EP1920418A4 (en) 2005-09-01 2010-12-29 Proteus Biomedical Inc Implantable zero-wire communications system
US7691151B2 (en) 2006-03-31 2010-04-06 Spiration, Inc. Articulable Anchor
US9011930B2 (en) * 2006-05-01 2015-04-21 Zycal Bioceuticals Healthcare Company, Inc. Nutritional supplement and use thereof
US8956287B2 (en) 2006-05-02 2015-02-17 Proteus Digital Health, Inc. Patient customized therapeutic regimens
US20080020037A1 (en) * 2006-07-11 2008-01-24 Robertson Timothy L Acoustic Pharma-Informatics System
WO2008062440A2 (en) * 2006-09-04 2008-05-29 Panacea Biotec Limited Programmable buoyant delivery technology
JP5916277B2 (en) 2006-10-25 2016-05-11 プロテウス デジタル ヘルス, インコーポレイテッド Ingestible control activation identifier
WO2008063626A2 (en) 2006-11-20 2008-05-29 Proteus Biomedical, Inc. Active signal processing personal health signal receivers
EP2121107B1 (en) * 2006-12-18 2012-10-31 Eatlittle Inc. Device for delivery of a substance
EP2107883A4 (en) 2007-02-01 2013-07-03 Proteus Digital Health Inc Ingestible event marker systems
CN103066226B (en) 2007-02-14 2016-09-14 普罗透斯数字保健公司 The body having a high surface area electrode power supply
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
US8932221B2 (en) 2007-03-09 2015-01-13 Proteus Digital Health, Inc. In-body device having a multi-directional transmitter
US20080287371A1 (en) * 2007-05-17 2008-11-20 Tranzyme Pharma Inc. Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex
US8540632B2 (en) 2007-05-24 2013-09-24 Proteus Digital Health, Inc. Low profile antenna for in body device
WO2009042812A1 (en) 2007-09-25 2009-04-02 Proteus Biomedical, Inc. In-body device with virtual dipole signal amplification
DK2268261T3 (en) 2008-03-05 2017-08-28 Proteus Digital Health Inc Edible event marking devices with multi-mode communications and systems and methods for using these
DE102008002397A1 (en) 2008-06-12 2009-12-17 Biotronik Vi Patent Ag An implantable device
MY154234A (en) 2008-07-08 2015-05-15 Proteus Digital Health Inc Ingestible event marker data framework
US8287902B2 (en) * 2008-07-23 2012-10-16 Rainbow Medical Ltd. Enhanced-diffusion capsule
AU2009281876B2 (en) 2008-08-13 2014-05-22 Proteus Digital Health, Inc. Ingestible circuitry
US9161911B2 (en) * 2008-08-15 2015-10-20 Depomed, Inc. Gastric retentive pharmaceutical compositions for treatment and prevention of CNS disorders
US20090176882A1 (en) 2008-12-09 2009-07-09 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same
EP2358270A4 (en) 2008-12-11 2014-08-13 Proteus Digital Health Inc Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same
CA2750158A1 (en) 2009-01-06 2010-07-15 Proteus Biomedical, Inc. Ingestion-related biofeedback and personalized medical therapy method and system
AU2010203737B2 (en) 2009-01-06 2016-09-15 Proteus Digital Health, Inc. Pharmaceutical dosages delivery system
US8540664B2 (en) 2009-03-25 2013-09-24 Proteus Digital Health, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
SG10201401867QA (en) 2009-04-28 2014-06-27 Proteus Digital Health Inc Highly Reliable Ingestible Event Markers And Methods For Using The Same
EP2432458A4 (en) 2009-05-12 2014-02-12 Proteus Digital Health Inc Ingestible event markers comprising an ingestible component
US20100331770A1 (en) * 2009-06-26 2010-12-30 Taris Biomedical, Inc. Implantable Drug Delivery Devices and Methods of Making the Same
EP2467707A4 (en) 2009-08-21 2014-12-17 Proteus Digital Health Inc Apparatus and method for measuring biochemical parameters
TWI517050B (en) 2009-11-04 2016-01-11 Proteus Digital Health Inc System for supply chain management
US9421169B2 (en) * 2009-11-20 2016-08-23 Covidien Lp Oral dosage forms for delivery of therapeutic agents
TWI532478B (en) 2009-12-02 2016-05-11 Proteus Digital Health Inc Pharmaceutical product and pharmaceutical tablet with an electronic marker
EP2544666A2 (en) 2010-03-09 2013-01-16 Council of Scientific and Industrial Research Gastroretentive, extended release composition of therapeutic agent
CN102905672B (en) 2010-04-07 2016-08-17 普罗秋斯数字健康公司 Micro swallowable device
WO2012071280A2 (en) 2010-11-22 2012-05-31 Proteus Biomedical, Inc. Ingestible device with pharmaceutical product
WO2012158553A2 (en) 2011-05-13 2012-11-22 Broncus Technologies, Inc. Methods and devices for excision of tissue
US8709034B2 (en) 2011-05-13 2014-04-29 Broncus Medical Inc. Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
US8658631B1 (en) 2011-05-17 2014-02-25 Mallinckrodt Llc Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia
US8858963B1 (en) 2011-05-17 2014-10-14 Mallinckrodt Llc Tamper resistant composition comprising hydrocodone and acetaminophen for rapid onset and extended duration of analgesia
US20140203950A1 (en) 2011-07-21 2014-07-24 Mark Zdeblick Mobile Communication Device, System, and Method
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
WO2013078235A1 (en) 2011-11-23 2013-05-30 Broncus Medical Inc Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
US20130143867A1 (en) 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2014018454A1 (en) 2012-07-23 2014-01-30 Proteus Digital Health, Inc. Techniques for manufacturing ingestible event markers comprising an ingestible component
MX340182B (en) 2012-10-18 2016-06-28 Proteus Digital Health Inc Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device.
WO2014144738A1 (en) 2013-03-15 2014-09-18 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
US10166207B2 (en) 2013-06-05 2019-01-01 Synchroneuron, Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
RU2016151697A (en) * 2014-06-02 2018-07-10 Тева Фармасьютикал Индастриз Лтд. Spreads dosage form is retained in the stomach
EP3155024A4 (en) 2014-06-11 2018-01-17 Massachusetts Institute Of Technology Residence structures and related methods
US9492396B2 (en) 2014-07-15 2016-11-15 Yossi Gross Enhanced drug delivery pill
WO2017096054A1 (en) 2015-12-01 2017-06-08 Teva Pharmaceutical Industries, Ltd. Gastric retentive devices
WO2017100367A1 (en) * 2015-12-08 2017-06-15 Lyndra, Inc. Geometric configurations for gastric residence systems
US10187121B2 (en) 2016-07-22 2019-01-22 Proteus Digital Health, Inc. Electromagnetic sensing and detection of ingestible event markers
AU2017336154A1 (en) * 2016-09-30 2019-04-18 Lyndra, Inc. Gastric residence systems for sustained delivery of adamantane-class drugs
CN107161363B (en) * 2017-05-27 2018-10-26 芜湖思科生产力促进中心有限公司 The average one material packing apparatus
WO2019060458A1 (en) * 2017-09-20 2019-03-28 Lyndra, Inc. Encapsulation of gastric residence systems

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU449029B2 (en) * 1969-08-28 1974-04-17
AU470538B2 (en) * 1972-05-15 1976-03-18
AU514312B2 (en) * 1976-06-02 1981-02-05 Malz Nominees Pty Ltd Device for administration to ruminant animals
AU520409B2 (en) * 1977-05-25 1982-01-28 Commw Scient Ind Res Org Controlled release composition
US4312347A (en) * 1980-02-25 1982-01-26 Iowa State University Research Foundation, Inc. Positive pressure drug releasing device
US4416659A (en) * 1981-11-09 1983-11-22 Eli Lilly And Company Sustained release capsule for ruminants
NZ200564A (en) * 1982-05-10 1987-03-06 Ahi Operations Ltd Device for slowly releasing chemicals into body cavities of animals
US4601893A (en) * 1984-02-08 1986-07-22 Pfizer Inc. Laminate device for controlled and prolonged release of substances to an ambient environment and method of use
AU588828B2 (en) * 1984-09-14 1989-09-28 Commonwealth Scientific And Industrial Research Organisation Controlled release capsule
US4687480A (en) * 1984-09-14 1987-08-18 Commonwealth Scientific And Industrial Research Organization Controlled release capsule
JPS6226215A (en) * 1985-05-10 1987-02-04 Merck & Co Inc Drug transmission device keeping in stomach during controlled time
EP0202159B1 (en) * 1985-05-10 1991-07-03 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US5002772A (en) * 1988-05-31 1991-03-26 Pfizer Inc. Gastric retention system for controlled drug release

Also Published As

Publication number Publication date
US5443843A (en) 1995-08-22
PT90702A (en) 1989-12-29
NO178426C (en) 1996-03-27
IE891782L (en) 1989-11-30
JPH0229268A (en) 1990-01-31
CA1335351C (en) 1995-04-25
FI892619A0 (en) 1989-05-30
AU609995B2 (en) 1991-05-09
DE68904596T2 (en) 1993-05-19
GR3007271T3 (en) 1993-07-30
NO892153D0 (en) 1989-05-29
FI892619D0 (en)
EP0344939A2 (en) 1989-12-06
AU3582689A (en) 1989-12-07
NZ229324A (en) 1990-09-26
IL90395A (en) 1993-01-14
DK262789D0 (en) 1989-05-30
KR910009396B1 (en) 1991-11-15
HUT50626A (en) 1990-03-28
PT90702B (en) 1993-09-30
FI99081B (en) 1997-06-30
DK262789A (en) 1989-12-01
NO178426B (en) 1995-12-18
ZA8904053B (en) 1991-01-30
IE62761B1 (en) 1995-02-22
ES2037419T3 (en) 1993-06-16
NO892153L (en) 1989-12-01
EP0344939B1 (en) 1993-01-27
FI99081C (en) 1997-10-10
FI892619A (en) 1989-12-01
IL90395D0 (en) 1990-01-18
DE68904596D1 (en) 1993-03-11
EP0344939A3 (en) 1990-01-24
US5002772A (en) 1991-03-26

Similar Documents

Publication Publication Date Title
DE68916015T2 (en) Double-fluid supply system.
DE68921798T2 (en) Therapeutic Nuleoside.
DE3878032T2 (en) Vehicle control system.
DE3850411T2 (en) Catheter.
DE68922894D1 (en) Pharmaceutical Ionenaustauscherharzzusammensetzung.
DE68911842D1 (en) Filter system.
DE69110467T2 (en) A device for delivery of drugs.
DE3889745D1 (en) Multi-area imaging system.
DE3776915D1 (en) Catheter for gefaesserweiterung.
DE68915380D1 (en) System for administering medicaments.
DE3751682D1 (en) Infectious system for drug delivery
AT72760T (en) A transdermal therapeutic system.
DK58988D0 (en) Sensor System
DE69001831T2 (en) Drug delivery device.
NO882568D0 (en) Dose delivering means.
NO902398D0 (en) Drug innhaleringsanordning.
DE3854044T2 (en) System for dual computer-check consistency.
DE69318027D1 (en) System for drug delivery
DE3880346T2 (en) Insulin derivatives.
DE3883624D1 (en) Speaker system.
DE3888730T2 (en) Speaker system.
DE3878123T2 (en) Geraet for ophthalmology.
DE3875705D1 (en) Carbidopa-levodopa-composition with controlled release.
DE3886558D1 (en) The holographic display system.
DE69224619D1 (en) Drug delivery system

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee